PODCASTS & PRESENTATIONS
ARTICLES
NEWS
December 18 2024
Holoclara’s announcement entering Phase 1 clinical trials and targeting Eosinophilic esophagitis is featured in Fierce Biotech. Learn more here.
September 20 2024
Holoclara’s first-in-class technology detailed in Forbes’ The Prototype.
Learn more here.
August 9 2024
Holoclara expands team with new addition of Head of Research and Development.
Learn more here.
June 27 2024
Holoclara announces $16M Series A Financing to advance a breakthrough class of worm-derived therapeutics for allergic and autoimmune disease.
Learn more here.
April 25 2024
Holoclara BOD member Peter B Hutt featured in Wall Street Journal, honoring the legacy he is creating in Food and Drug Law.
Learn more here.
March 2024
CEO Andrea Choe participates in “Demystifying Aging” panel at Horizons Venture’s Techcracker Summit.
Find out more about Horizons Ventures here.
March 2024
CEO Andrea Choe joins Solina Chau, Jennifer Doudna, and other entrepreneurs to discuss innovation with students at Tokyo Medical and Dental University.
Learn more here.
